Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNYNF)
OTHER OTC:SNYNF
SNYNF Analyst Ratings
Moderate Buy
9 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SNYNF Stock 12 Month Forecast
Average Price Target
$124.34
▲(10.65% Upside)
| Highest Price Target$134.94 | Average Price Target$124.34 | Lowest Price Target$99.32 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
J.P. Morgan
Reiterated
03/25/25
Deutsche Bank
Reiterated
03/21/25
Goldman Sachs
Initiated
03/21/25
Leerink Partners
Reiterated
03/20/25
Bernstein
Reiterated
03/11/25
Jefferies
Reiterated
03/10/25
Berenberg Bank
Reiterated
03/04/25
DZ BANK AG
Upgraded
01/31/25
Bank of America Securities
Reiterated
01/31/25
Barclays
$129.54→$134.94
Buy
20.09%
Upside
Reiterated
01/31/25
Sanofi (SAN:FP) (SNY) PT Raised to EUR125 at BarclaysBarclays analyst Emily Field raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR125.00 (from EUR120.00) while maintaining a Overweight rating.
Stifel Nicolaus
$132.78
Buy
18.16%
Upside
Reiterated
01/30/25
Sanofi's Strong Growth Prospects and Strategic Initiatives Justify Buy Rating
Kepler Capital
$99.32
Hold
-11.62%
Downside
Reiterated
01/30/25
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
Citi
$134.94→$140.34
Buy
24.89%
Upside
Reiterated
09/16/24
Sanofi (SAN:FP) (SNY) PT Raised to EUR130 at Citi, sees 'a highly attractive risk-reward'Citi analyst Peter Verdult raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR130.00 (from EUR125.00) while maintaining a Buy rating.
Guggenheim
$127.38→$134.94
Buy
20.09%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
Reiterated
03/25/25
Deutsche Bank
Reiterated
03/21/25
Goldman Sachs
Initiated
03/21/25
Leerink Partners
Reiterated
03/20/25
Bernstein
Reiterated
03/11/25
Jefferies
Reiterated
03/10/25
Berenberg Bank
Reiterated
03/04/25
DZ BANK AG
Upgraded
01/31/25
Bank of America Securities
Reiterated
01/31/25
Barclays
$129.54→$134.94
Buy
20.09%
Upside
Reiterated
01/31/25
Sanofi (SAN:FP) (SNY) PT Raised to EUR125 at BarclaysBarclays analyst Emily Field raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR125.00 (from EUR120.00) while maintaining a Overweight rating.
Stifel Nicolaus
$132.78
Buy
18.16%
Upside
Reiterated
01/30/25
Sanofi's Strong Growth Prospects and Strategic Initiatives Justify Buy Rating
Kepler Capital
$99.32
Hold
-11.62%
Downside
Reiterated
01/30/25
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
Citi
$134.94→$140.34
Buy
24.89%
Upside
Reiterated
09/16/24
Sanofi (SAN:FP) (SNY) PT Raised to EUR130 at Citi, sees 'a highly attractive risk-reward'Citi analyst Peter Verdult raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR130.00 (from EUR125.00) while maintaining a Buy rating.
Guggenheim
$127.38→$134.94
Buy
20.09%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
SNYNF Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
23
15
16
20
20
Hold
8
8
7
8
10
Sell
5
5
2
2
0
Strong Sell
0
0
0
0
0
total
36
28
25
30
30
Each month's total comprises the sum of three months' worth of ratings.
SNYNF Financial Forecast
SNYNF Stock Forecast FAQ
What is SNYNF’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is $124.34.
What is SNYNF’s upside potential, based on the analysts’ average price target?
Sanofi has 10.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SNYNF a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy which is based on 9 buy ratings, 4 hold ratings and 0 sell ratings.
What is Sanofi’s price target?
The average price target for Sanofi is $124.34. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $134.94 ,the lowest forecast is $99.32. The average price target represents 10.65% Increase from the current price of $112.37.
The highest analyst price target is $134.94 ,the lowest forecast is $99.32. The average price target represents 10.65% Increase from the current price of $112.37.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of SNYNF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.